August Health vs Regeneron Pharmaceuticals
Side-by-side comparison of AI visibility scores, market position, and capabilities
Assisted living operations and care management platform built for modern senior living communities, replacing paper-based workflows with AI-assisted assessments and digital care planning.
About
August Health is a San Francisco, California-based senior care technology company building a modern cloud-native platform for assisted living and memory care communities. Founded in 2019 and having raised over $14 million from investors including a16z and others, August Health targets the large segment of senior living communities still operating on paper-based or legacy software workflows. The company's platform digitizes resident assessments, care planning, incident reporting, medication management, and family communication in a design-forward interface built for use by care staff on mobile devices.\n\nA key differentiator for August Health is its use of AI to assist care staff in completing state-required assessments and care plans. The platform can generate draft care plan language based on assessment responses, reducing the documentation burden on caregivers while improving consistency and completeness of clinical records. This AI-assisted documentation capability is particularly valuable in assisted living, where staffing challenges and high turnover make efficient documentation workflows critical to operational quality.\n\nAugust Health competes with established vendors like Yardi Senior Living and MatrixCare but targets smaller independent communities and regional groups that find legacy platforms overly complex and expensive for their needs. The company's modern UX, mobile-first design, and AI-assisted features position it as a next-generation alternative in a market where much of the installed base runs on software designed before smartphones existed. As the senior care sector faces mounting staffing pressure, technology that reduces administrative burden on direct care staff is increasingly valued by operators.
Regeneron (REGN) reported $13.9B revenue in FY2024, up 7% YoY. Top biotech company. Dupixent franchise >$14B. Leaders in eye disease, immunology, oncology. HQ: Tarrytown, NY.
About
Regeneron Pharmaceuticals, Inc. is a leading biotechnology company specializing in the discovery, development, and commercialization of medicines for serious diseases, headquartered in Tarrytown, New York. Founded in 1988 by Leonard Schleifer and George Yancopoulos, Regeneron developed its own proprietary drug discovery technology platform (VelociGene, VelocImmune) that has enabled the development of multiple breakthrough medicines. The company reported revenues of $13.9B in FY2024, up 7% year-over-year.
AI Visibility Head-to-Head
Key Details
Capabilities & Ecosystem
Capabilities
Integrations
Also Compare
Track AI Visibility in Real Time
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.